If you would like to submit a blog post for consideration, please email admin@healthcert.com

[3 min read] Cardiovascular disease and type 2 diabetes in adults with atopic dermatitis

atopic dermatitis

Is there an association with cardiovascular disease and type 2 diabetes in adults with atopic dermatitis? A study published in the British Journal of Dermatology examined this via a systematic review and meta-analysis. The study compared the risk of cardiovascular disease and diabetes for adult patients with and without atopic dermatitis by searching the PubMed, Embase […]

[WEBINAR] How to set up a successful practice ownership structure

webinar

[WEBINAR] Do you know how to set up a fair and transparent business ownership structure that considers your lifestyle and changes in your circumstances? In the webinar below, our CEO Paul Elmslie explains the key elements you need in order to support a thriving business partnership, with detailed models to assist you with fluid communication, […]

[3 min read] Stem cells for the treatment of alopecia

alopecia

Managing alopecia areata and androgenetic alopecia is often challenging as patients may be resistant to treatments that are currently available. The use of stem cells may be a novel option for resistant cases. A study looked at the safety and efficacy of the use of autologous bone marrow derived mononuclear cells (including stem cells) as […]

[3 min read] Million Metres for Melanoma: sharing our vision of a world where nobody dies from skin cancer

million metres for melanoma

HealthCert has partnered with the Skin Cancer Institute to become a bronze sponsor of the Million Metres for Melanoma initiative. Together, we share the vision of a world where nobody dies from skin cancer.

Alopecia: 5‐alpha‐reductase inhibitor treatment

alopecia

Do you find treatment challenging for frontal fibrosing alopecia? Its treatment regimen often mirrors other lymphocytic‐predominant cicatricial alopecia. 5‐alpha‐reductase inhibitor has been reported with some treatment success in severe cases of frontal fibrosing alopecia, so researchers recently carried out an analysis of articles published on treatment efficacy and safety of 5‐alpha‐reductase inhibitor for the treatment of the […]

[WEBINAR] How to recruit and terminate staff

WEBINAR

[WEBINAR] Do you know how to recruit and retain the right staff for your medical practice? As employees are your most valuable asset that will push your business towards growth and success, it is important to find a talented and motivated workforce and terminate the under-performers in a timely manner.

Fluorouracil vs imiquimod for the treatment of actinic keratosis

actinic keratosis

The most widely used topical agents for the field-based treatment of multiple actinic keratoses are 5-fluorouracil and imiquimod. Their comparative effectiveness was assessed in a real-world community-based cohort study published in the Journal of the American Academy of Dermatology. The study compared the effectiveness of 5-fluorouracil and imiquimod in reducing risk for subsequent actinic keratoses. It […]

Pityriasis rosea during pegnancy

pityriasis rosea

Pityriasis rosea is a skin rash that sometimes begins as a large spot on the chest, abdomen or back, followed by a pattern of smaller lesions. It is a self-limiting exanthematous disease associated with human herpesvirus (HHV)-6 and/or HHV-7 reactivation. In pregnant women, the condition may be associated with pregnancy complications.

Managing pregnancy-related hypothyroidism in your practice

Hypothyroidism

Did you know an under-active thyroid during pregnancy carries increased risks for both the mother and the baby, including diabetes, hypertension and even miscarriage? Watch the five-minute video below to learn more about managing hypothyroidism in pregnancy.

Are eczema patients at an increased risk of cardiovascular disease?

eczema

Are adults with atopic dermatitis (eczema) at an increased risk of cardiovascular disease? A matched cohort study undertaken in the UK looked at this topic, and also investigated whether the risk varies by eczema severity and condition activity over time.

Subscribe